RUNX3 and gastric cancer: Based on their results, tumorigenicity of human gastric cancer-derived cells was inversely correlated with RUNX3 expression level and mutation within the genomic region encoding Runt domain of RUNX3 (R122C) abrogated its tumor suppressive activity.